» Articles » PMID: 17459586

Mast Cell Degranulation Activates a Pain Pathway Underlying Migraine Headache

Overview
Journal Pain
Specialties Neurology
Psychiatry
Date 2007 Apr 27
PMID 17459586
Citations 162
Authors
Affiliations
Soon will be listed here.
Abstract

Intracranial headaches such as that of migraine are generally accepted to be mediated by prolonged activation of meningeal nociceptors but the mechanisms responsible for such nociceptor activation are poorly understood. In this study, we examined the hypothesis that meningeal nociceptors can be activated locally through a neuroimmune interaction with resident mast cells, granulated immune cells that densely populate the dura mater. Using in vivo electrophysiological single unit recording of meningeal nociceptors in the rat we observed that degranulation of dural mast cells using intraperitoneal administration of the basic secretagogue agent compound 48/80 (2 mg/kg) induced a prolonged state of excitation in meningeal nociceptors. Such activation was accompanied by increased expression of the phosphorylated form of the extracellular signal-regulated kinase (pERK), an anatomical marker for nociceptor activation. Mast cell-induced nociceptor interaction was also associated with downstream activation of the spinal trigeminal nucleus as indicated by an increase in c-fos expression. Our findings provide evidence linking dural mast cell degranulation to prolonged activation of the trigeminal pain pathway believed to underlie intracranial headaches such as that of migraine.

Citing Articles

Comorbidities as risk factors for migraine onset: A systematic review and three-level meta-analysis.

Terhart M, Overeem L, Hong J, Reuter U, Raffaelli B Eur J Neurol. 2025; 32(3):e16590.

PMID: 40040320 PMC: 11880117. DOI: 10.1111/ene.16590.


The link between spreading depolarization and innate immunity in the central nervous system.

Soylu K, Yemisci M, Karatas H J Headache Pain. 2025; 26(1):25.

PMID: 39901107 PMC: 11792447. DOI: 10.1186/s10194-024-01938-5.


Topiramate Inhibits Capsaicin-Induced Mast Cell Degranulation and CGRP Release in Rat Dura Mater.

Costa R, Rosas E, Paz S, Freitas M, de Souza S, Andrade J Brain Sci. 2024; 14(11).

PMID: 39595833 PMC: 11592047. DOI: 10.3390/brainsci14111070.


Interplay between cannabinoids and the neuroimmune system in migraine.

Zorrilla E, Della Pietra A, Russo A J Headache Pain. 2024; 25(1):178.

PMID: 39407099 PMC: 11481476. DOI: 10.1186/s10194-024-01883-3.


Meningeal brain borders and migraine headache genesis.

Christensen S, Levy D Trends Neurosci. 2024; 47(11):918-932.

PMID: 39304416 PMC: 11563857. DOI: 10.1016/j.tins.2024.08.012.


References
1.
Levy D, Strassman A . Distinct sensitizing effects of the cAMP-PKA second messenger cascade on rat dural mechanonociceptors. J Physiol. 2002; 538(Pt 2):483-93. PMC: 2290080. DOI: 10.1113/jphysiol.2001.013175. View

2.
Bolay H, Reuter U, Dunn A, Huang Z, Boas D, Moskowitz M . Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model. Nat Med. 2002; 8(2):136-42. DOI: 10.1038/nm0202-136. View

3.
Rozniecki J, Dimitriadou V, Pang X, Theoharides T . Morphological and functional demonstration of rat dura mater mast cell-neuron interactions in vitro and in vivo. Brain Res. 1999; 849(1-2):1-15. DOI: 10.1016/s0006-8993(99)01855-7. View

4.
Ribeiro R, Vale M, Thomazzi S, Paschoalato A, Poole S, Ferreira S . Involvement of resident macrophages and mast cells in the writhing nociceptive response induced by zymosan and acetic acid in mice. Eur J Pharmacol. 2000; 387(1):111-8. DOI: 10.1016/s0014-2999(99)00790-6. View

5.
Sheftell F, Rapoport A, Weeks R, Walker B, Gammerman I, Baskin S . Montelukast in the prophylaxis of migraine: a potential role for leukotriene modifiers. Headache. 2000; 40(2):158-63. DOI: 10.1046/j.1526-4610.2000.00022.x. View